Income statement revenue $266.04M (+25.9% YoY).Operating income $40.46M (+191.2% YoY).Pre-tax result $37.1M (+252.5% YoY).Net result $24.71M (+189.1% YoY).

Generics And Other: $100.66M (+6.8% YoY)
Rare Disease And Brands: $165.39M (+41.2% YoY)
Operating costs: $125.43M
Other expense: $3.36M (-0.1% YoY)
Income tax expense: $12.39M (+526.8% YoY)

Loading financials

Income statement income statement flow. Revenue $266.04M. Net result $24.71M.

Income statement revenue $266.04M (+25.9% YoY).Operating income $40.46M (+191.2% YoY).Pre-tax result $37.1M (+252.5% YoY).Net result $24.71M (+189.1% YoY).

Generics And Other: $100.66M (+6.8% YoY)
Rare Disease And Brands: $165.39M (+41.2% YoY)
Operating costs: $125.43M
Other expense: $3.36M (-0.1% YoY)
Income tax expense: $12.39M (+526.8% YoY)